PTCH1 and basal cell carcinoma: Mutations in the gene that codes for the protein or the trans-membrane receptor PTCH1 have been previously described in patients with Gorlin syndrome, which is associated with a higher risk for harboring Basal Cell Carcinomas (BCC) [59].